rs2505059
From SNPedia
Orientation | minus |
Stabilized | minus |
Make rs2505059(C;C) |
Make rs2505059(C;T) |
Make rs2505059(T;T) |
Reference | GRCh38 38.1/141 |
Chromosome | 6 |
Position | 98048076 |
is a | snp |
is | mentioned by |
dbSNP | rs2505059 |
dbSNP (classic) | rs2505059 |
ClinGen | rs2505059 |
ebi | rs2505059 |
HLI | rs2505059 |
Exac | rs2505059 |
Gnomad | rs2505059 |
Varsome | rs2505059 |
LitVar | rs2505059 |
Map | rs2505059 |
PheGenI | rs2505059 |
Biobank | rs2505059 |
1000 genomes | rs2505059 |
hgdp | rs2505059 |
ensembl | rs2505059 |
geneview | rs2505059 |
scholar | rs2505059 |
rs2505059 | |
pharmgkb | rs2505059 |
gwascentral | rs2505059 |
openSNP | rs2505059 |
23andMe | rs2505059 |
SNPshot | rs2505059 |
SNPdbe | rs2505059 |
MSV3d | rs2505059 |
GWAS Ctlg | rs2505059 |
GMAF | 0.4669 |
Max Magnitude | 0 |
? | (C;C) (C;T) (T;T) | 28 |
---|---|---|
|
GWAS snp | |
---|---|
PMID | [PMID 23648065] |
Trait | Adverse response to chemotherapy (neutropenia/leucopenia) (all anthracycline-based drugs) |
Title | Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan. |
Risk Allele | G |
P-val | 5E-6 |
Odds Ratio | 1.77 [1.383-2.252] |